ARAY News and Press, Accuray Incorporated From 11/07/23

Accuray Incorporated (ARAY) is expected to report $-0.03 for Q1 2024

Accuray to Participate in the 14th Annual Jefferies London Healthcare Conference PR Newswire MADISON, Wis. , Oct. 31, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the 14 th Annual Jefferies London Healthcar...

Accuray to Report First Quarter Fiscal 2024 Financial Results on November 7, 2023 PR Newswire MADISON, Wis. , Oct. 26, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2024, ended Se...

2023-10-26 09:09:57 ET More on Accuray With Chinese Type B Approval In Hand, 'Now Or Never' Approaches For Accuray Accuray Incorporated - Impressive Growth As Orders Expands Accuray Incorporated (ARAY) Q2 2023 Earnings Call Transcript Accuray gains as China c...

2023-10-06 00:23:37 ET Summary Accuray's China JV recently received approval to sell its locally-produced Tomo C rad-onc system for China's Type B market - an opportunity that management estimates at $3B over 5 years. Management has a good track record in China, but there's a long...

2023-10-04 13:57:06 ET More on Accuray Accuray Incorporated - Impressive Growth As Orders Expands Accuray Incorporated (ARAY) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Accuray Historical earnings data for Accuray Financia...

Accuray Incorporated (NASDAQ: ARAY) is one of today's top gainers. The company's shares are currently up 9.81% on the day to $2.85. Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, th...

2023-10-04 09:59:33 ET More on Health Care Select Sector SPDR September Labor Report Preview: Full Employment To Infinity Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Citi turns cautious on pharmaceuticals and biotech BofA Securities:...

Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration PR Newswire MADISON, Wis. , Oct. 3, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the regist...

Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting PR Newswire MADISON, Wis. , Oct. 2, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced to...